Prevalence of amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors

Journal of Medical Virology

Volumn 83, Issue 11, 2011, Pages 1924-1929

  Furui, Yasumi ^a   Hoshi, Yuji ^a   Murata, Kazumoto ^b   Ito, Kiyoaki ^b   Suzuki, Kou ^a   Uchida, Shigeharu ^a   Satake, Masahiro ^a   Mizokami, Masashi ^b   Tadokoro, Kenji ^a  

^a Japanese Red Central Blood Center   (Japan)

^b 1 7 1 Kohnodai   (Japan)

Author keywords

Acute HCV infection; Blood donors; HCV core mutation; HCV genotype; Window period

Indexed keywords

AMINO ACID; VIRUS RNA;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD DONOR; FEMALE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; RNA ANALYSIS; SEROLOGY; TREND STUDY; VIRUS CORE; VOLUNTEER;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; BLOOD DONORS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMAN EXPERIMENTATION; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MUTATION, MISSENSE; PREVALENCE; RNA, VIRAL; VIRAL CORE PROTEINS; VIRAL LOAD; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 80052730555     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22216     Document Type: Article

References (16)

1. Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Matsuda M, Kobayashi M, Arase Y, Ikeda K, Kumada H. 2005. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. Intervirology 48: 372-380.
2. +T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 201: 1709-1714.
3. El-Shamy A, Kim SR, Ide YH, Sasase N, Imoto S, Deng L, Shoji I, Hotta H. 2011. Polymorphisms of hepatitis C virus non-structural protein 5a and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy. Intervirology [Epub ahead of print] DOI: 10.1159/000322219.
4. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334: 77-81.
5. Hanada K, Tanaka Y, Mizokami M, Gojobori T, Alter HJ. 2007. A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation. Virology 361: 27-33.
6. Kim WR. 2002. Global epidemiology and burden of hepatitis C. Microbes Infect 4: 1219-1225.
7. Kuntzen T, Timm J, Berical A, Lewis-Ximenez LL, Jones A, Nolan B, Wiesch JS, Li B, Schneidewind A, Kim AY, Chung RT, Lauer GM, Allen TM. 2007. Viral sequence evolution in acute hepatitis C virus infection. J Virol 81: 11658-11668.
8. Kurbanov F, Tanaka Y, Matsuura K, Sugauchi F, Elkady A, Khan A, Hasegawa I, Ohno T, Tokuda H, Mizokami M. 2010. Positive selection of core 70Q variant genotype 1b hepatitis C virus strains induced by pegylated interferon and ribavirin. J Infect Dis 201: 1663-1671.
9. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. 2000. Pathogensis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132: 296-305.
10. Lole KS, Jha JA, Shrotri SP, Tandon BN, Prasad VGM, Arankalle VA. 2003. Comparison of hepatitis C virus genotyping by 5' noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol 41: 5240-5244.
11. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J Virol 66: 3225-3229.
12. Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, Yamanaka R, Yoshikawa A, Nishioka K, Japanese Red Cross NAT Research Group. 2003. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods 112: 145-151.
13. Murokawa H, Yoshikawa A, Ohnuma H, Iwata A, Katoh N, Miyamoto M, Mine H, Emura H, Tadokoro K, Japanese Red Cross NAT Screening Research Group. 2005. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang 88: 10-16.
14. Ohno T, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JYN. 1997. New hepatitis C virus (HCV) genotyping system that allows for indentification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35: 201-207.
15. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, Mishiro S. 1993. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 74: 2385-2390.
16. Tanaka E, Kiyosawa K, Matsushima T, Ishikawa K, Hino K, Tanaka S, Nose H, Kumada H, Iino S, Kamimura T, Unoura M, Mizokami M, Okanoue T, Kuroki T, Yamada G, Miura T, Yano M, Tsubouchi H, Kohara M, Sato S, Hattori N, Genotyping Elisa Study Group. 1995. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver disease: A multi-institution analysis. J Gastroenterol Hepatol 10: 538-545.